Compound information
- Natural Products
- ZC3526293
- Molecular Formula
- C33H44N4O7S
- Molecular Weight
- 640.293070748 g/mol
- Structure
-
- IUPAC Name
- tert-butyl N-[(1R)-5-(benzyloxycarbonylamino)-1-[[5-(isobutylsulfamoyl)-1-naphthyl]carbamoyl]pentyl]carbamate
- InChI
- InChI=1S/C33H44N4O7S/c1-23(2)21-35-45(41,42)29-19-12-15-25-26(29)16-11-18-27(25)36-30(38)28(37-32(40)44-33(3,4)5)17-9-10-20-34-31(39)43-22-24-13-7-6-8-14-24/h6-8,11-16,18-19,23,28,35H,9-10,17,20-22H2,1-5H3,(H,34,39)(H,36,38)(H,37,40)/t28-/m1/s1
- InChI Key
- YIBIADOZEJSNQF-MUUNZHRXSA-N
- SMILES
- CC(C)CNS(=O)(=O)c1cccc2c(NC(=O)[C@@H](CCCCNC(=O)OCc3ccccc3)NC(=O)OC(C)(C)C)cccc12
- Source
- ZINC000102154616
Warheads
- Carbamate
-
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 45 | Ring Count | 3 |
Heteroatom Count | 12 | Rotatable Bond Count | 14 |
Hydrogen Bond Acceptor Count | 7 | Hydrogen Bond Donor Count | 4 |
Topological Polar Surface Area | 151.93 Å2 | LogP | 5.17 |
LogS | -6.356 | LogD | 4.434 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.79 | Pgp substrate | 0.98 |
HIA | 0.97 | F20 % | 0.985 |
F30 % | 0.009 | Caco-2 | -5.72 |
MDCK | -5.669 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.097 | PPB | 92.497 |
VD | 1.014 | Fu | 2.373 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.531 | CYP1A2 substrate | 0.546 |
CYP2A6 substrate | 0.32 | CYP2B6 substrate | 0.608 |
CYP2C19 inhibitor | 0.99 | CYP2C19 substrate | 0.857 |
CYP2C8 substrate | 0.851 | CYP2C9 inhibitor | 0.916 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.298 |
CYP2D6 substrate | 0.898 | CYP2E1 substrate | 0.332 |
CYP3A4 inhibitor | 0.995 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.502 | CL | 3.668 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.022 | Hepatotoxicity | 0.995 |
Mutagenicity | 0.037 | Rat Oral Acute Toxicity | 0.245 |
FDAMDD | 0.446 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.008 | Eye Corrosion | 0.002 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.026 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.596 | IGC50 | 4.943 |
LC50FM | 4.713 | LC50DM | 5.269 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.179 | NR-AR-LBD | 0.233 |
NR-AhR | 0.106 | NR-Aromatase | 0.073 |
NR-ER | 0.483 | NR-ER-LBD | 0.4 |
NR-PPAR-gamma | 0.794 | SR-ARE | 0.776 |
SR-ATAD5 | 0.419 | SR-HSE | 0.047 |
SR-MMP | 0.82 | SR-p53 | 0.091 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.